Status:

RECRUITING

Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis

Lead Sponsor:

Northwestern University

Conditions:

Gastroparesis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a prospective sham study to investigate the role of transpyloric stenting with lumen apposing metal stent (LAMS) as a predictor for clinical response to gastric per-oral endoscopic pyloromyoto...

Detailed Description

Gastroparesis is defined as a complex syndrome of symptoms including early satiety, post-prandial fullness, nausea, vomiting, bloating, and upper abdominal pain with a corresponding objective delay in...

Eligibility Criteria

Inclusion

  • Adult patients greater than 18 years of age with gastroparesis refractory to standard medical therapy (lifestyle and diet modifications, prokinetics) or contraindication to standard therapies (e.g. allergies to prokinetic agents)
  • Patients with diabetic, idiopathic or post-surgical gastroparesis
  • Patients with confirmed diagnosis of gastroparesis via gastric emptying study (abnormal gastric emptying will be defined as ≥10 % residual activity at 4 h on a standardized nuclear medicine TC-99 m sulfur colloid solid-phase gastric emptying study)

Exclusion

  • Patients with prior history of gastroenteric anastomosis or any GI surgeries with pyloric involvement
  • Patients with gastroesophageal malignancy
  • Patients who are unable to tolerate upper endoscopy secondary to cardiopulmonary instability or other contraindications to endoscopy
  • Patients with cirrhosis
  • Patients who are pregnant or breastfeeding
  • Patients with uncorrectable coagulopathy defined by INR \>1.5 or platelets \<50

Key Trial Info

Start Date :

May 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 6 2026

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT04287647

Start Date

May 15 2019

End Date

June 6 2026

Last Update

February 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwestern University

Chicago, Illinois, United States, 60611

Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis | DecenTrialz